UAE health authorities have withdrawn a low-dose aspirin tablet which is used to treat pain and reduce fever or inflammation. The Ministry of Health and Prevention (MoHAP) in Dubai has declared the abolition of Jusprin 81 mg tablets for failing to meet the required regulatory standards.
The Gulf Pharmaceutical Industries (Julphar) manufactured tablet, Jusprin 81, was also advised to treat or prevent heart attacks, strokes and chest pain.
According to the circular, the Gulf Cooperation Council (GCC) had set guidelines for the pharmaceuticals and the company has not followed the guidelines.
The doctors and pharmacists were requested by the circular to stop prescribing the Jusprin 81 tablets and to return the stocks to the supplier. The suppliers were also requested to withdraw the tablets from public and private institutions.
The circular stated that “the supplier shall withdraw the above-mentioned product from the government and private sectors, all health care practitioners should not use the product, [and] all pharmacies must stop dispensing the above-mentioned product and return it to the supplier”.
Residents were urged to send an email to the Ministry of Health and Prevention’s website at firstname.lastname@example.org to report any harmful reaction by the drug. The citizen can also contact the Drug Control Section via email at DrugControl@dha.gov.ae.